Science Explorer Back to mapMap
Research facility · Nashville · United States

Sarah Cannon

In research, Sarah Cannon stands highest in Health Sciences (#1,558 of 9,902 worldwide), Medicine (#1,774 of 8,541 worldwide) and Oncology (#324 of 755 worldwide), 2022-now. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine (Oncology is 22.4× its share of world research).

World rank, 2022-now
#8,145
of 22,385 · #5,078 all time
Rank in United States
#1,098
of 3,332
Research works
1.2k
▲ 24% vs 2018-21
Citations
36k
30.6 per fractional work
Top-10% rate
21.0%
all institutions 10.0%
vs its own fields
1.12×
1.00× is exactly expected
Open access
31%
world 40%
International
31%
world 18%

What is Sarah Cannon known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #1,558 of 9,902 22.9%191 #1569
MedicineField #1,774 of 8,541 22.9%187 #1753
OncologySubfield #324 of 755 21.3%75 #373
Life SciencesDomain #3,213 of 6,403 23.7%65 #3258

Each strip is that field's whole ranked pool, with the notch where Sarah Cannon sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Health Sciences#1,569 #1,558
  2. Medicine#1,753 #1,774
  3. Oncology#373 #324
  4. Life Sciences#3,258 #3,213
all time2022-now, better2022-now, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

Which fields of science does Sarah Cannon work in?

In 2022-now, 66% of research at Sarah Cannon is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (65%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (4%). It does 2.8× the world's share of Health Sciences.

Health Sciences: 225 fractional works · 65.9% of its workMedicine: 220 fractional works · 64.5% of its workOncology: 86 fractional works · 25.2% of its workPulmonary and Respiratory Medicine: 36 fractional works · 10.4% of its workRadiology, Nuclear Medicine and Imaging: 15 fractional works · 4.4% of its workHematology: 13 fractional works · 3.8% of its workGenetics: 10 fractional works · 2.9% of its workPathology and Forensic Medicine: 10 fractional works · 2.8% of its workPhysiology: 9 fractional works · 2.7% of its workSurgery: 8 fractional works · 2.4% of its workPublic Health, Environmental and Occupational Health: 5 fractional works · 1.4% of its workEpidemiology: 4 fractional works · 1.3% of its workReproductive Medicine: 3 fractional works · 0.8% of its workPediatrics, Perinatology and Child Health: 2 fractional works · 0.7% of its workGastroenterology: 2 fractional works · 0.6% of its workHepatology: 2 fractional works · 0.6% of its workOtorhinolaryngology: 2 fractional works · 0.6% of its workNeurology: 2 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.4% of its workHealth Informatics: 1 fractional works · 0.3% of its workInfectious Diseases: 1 fractional works · 0.3% of its workRheumatology: 1 fractional works · 0.3% of its workObstetrics and Gynecology: 1 fractional works · 0.3% of its workPharmacology: 1 fractional works · 0.3% of its workDermatology: 1 fractional works · 0.2% of its workPsychiatry and Mental health: 1 fractional works · 0.2% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.2% of its workOphthalmology: 1 fractional works · 0.2% of its workSmaller subfields together: 3 fractional works · 0.8% of its workHealth Professions: 4 fractional works · 1.1% of its workGeneral Health Professions: 2 fractional works · 0.5% of its workHealth Information Management: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDentistry: 1 fractional works · 0.2% of its workNursing: 0 fractional works · 0.1% of its workLife Sciences: 81 fractional works · 23.8% of its workBiochemistry, Genetics and Molecular Biology: 62 fractional works · 18.1% of its workMolecular Biology: 33 fractional works · 9.8% of its workCancer Research: 18 fractional works · 5.2% of its workGenetics: 5 fractional works · 1.4% of its workBiotechnology: 3 fractional works · 0.8% of its workBiophysics: 1 fractional works · 0.4% of its workCell Biology: 1 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.2% of its workImmunology and Microbiology: 14 fractional works · 4.2% of its workImmunology: 14 fractional works · 4.1% of its workSmaller subfields together: 0 fractional works · 0.0% of its workNeuroscience: 3 fractional works · 0.9% of its workSensory Systems: 1 fractional works · 0.4% of its workSmaller subfields together: 2 fractional works · 0.5% of its workAgricultural and Biological Sciences: 1 fractional works · 0.4% of its workPlant Science: 1 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.2% of its workSocial Sciences: 22 fractional works · 6.5% of its workEconomics, Econometrics and Finance: 10 fractional works · 2.9% of its workEconomics and Econometrics: 10 fractional works · 2.9% of its workPsychology: 6 fractional works · 1.8% of its workSocial Psychology: 3 fractional works · 0.7% of its workExperimental and Cognitive Psychology: 2 fractional works · 0.5% of its workClinical Psychology: 1 fractional works · 0.3% of its workDevelopmental and Educational Psychology: 1 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 2 fractional works · 0.7% of its workEducation: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.4% of its workDecision Sciences: 2 fractional works · 0.6% of its workManagement Science and Operations Research: 1 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.3% of its workArts and Humanities: 2 fractional works · 0.5% of its workHistory and Philosophy of Science: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.2% of its workPhysical Sciences: 13 fractional works · 3.8% of its workEngineering: 3 fractional works · 0.9% of its workBiomedical Engineering: 3 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 3 fractional works · 0.7% of its workArtificial Intelligence: 1 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.4% of its workEarth and Planetary Sciences: 2 fractional works · 0.7% of its workGeochemistry and Petrology: 2 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 2 fractional works · 0.5% of its workStatistics and Probability: 2 fractional works · 0.5% of its workMaterials Science: 1 fractional works · 0.4% of its workChemistry: 1 fractional works · 0.3% of its workOrganic Chemistry: 1 fractional works · 0.3% of its workChemical Engineering: 1 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workALL ITS WORKSarah Cannon341fractional works, 2022-now
Life Sciences24%Physical Sciences4%Health Sciences66%Social Sciences6%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 24 fields, with their numbers
    1. Medicine22064.5%
    2. Health Professions41.1%
    3. Dentistry10.2%
    4. Nursing00.1%
    1. Biochemistry, Genetics and Molecular Biology6218.1%
    2. Immunology and Microbiology144.2%
    3. Neuroscience30.9%
    4. Agricultural and Biological Sciences10.4%
    5. Pharmacology, Toxicology and Pharmaceutics10.2%
    1. Economics, Econometrics and Finance102.9%
    2. Psychology61.8%
    3. Social Sciences20.7%
    4. Decision Sciences20.6%
    5. Arts and Humanities20.5%
    6. Business, Management and Accounting00.0%
    1. Engineering30.9%
    2. Computer Science30.7%
    3. Earth and Planetary Sciences20.7%
    4. Mathematics20.5%
    5. Materials Science10.4%
    6. Chemistry10.3%
    7. Chemical Engineering10.2%
    8. Physics and Astronomy00.1%
    9. Environmental Science00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Sarah Cannon specialise in?

Where its research is concentrated relative to its size: Oncology takes 22.4× the share of its output that it takes of world research.

  1. OncologySubfield · 86.1 works22×
  2. Pulmonary and Respiratory MedicineSubfield · 35.5 works6.8×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.40× its world share, 62 worksBiochemistry, Geneti…Immunology and Microbiology: 4.13× its world share, 14 worksImmunology and Micro…Neuroscience: 0.53× its world share, 3 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.69× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.56× its world share, 1 worksChemical EngineeringChemistry: 0.21× its world share, 1 worksChemistryComputer Science: 0.09× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.43× its world share, 2 worksEarth and Planetary …Engineering: 0.06× its world share, 3 worksEngineeringMaterials Science: 0.10× its world share, 1 worksMaterials ScienceMathematics: 0.43× its world share, 2 worksMathematicsPhysics and Astronomy: 0.03× its world share, 0 worksPhysics and AstronomyDentistry: 0.38× its world share, 1 worksDentistryHealth Professions: 0.40× its world share, 4 worksHealth ProfessionsMedicine: 3.36× its world share, 220 worksMedicineNursing: 0.25× its world share, 0 worksNursingArts and Humanities: 0.19× its world share, 2 worksArts and HumanitiesBusiness, Management and Accounting: 0.01× its world share, 0 worksBusiness, Management…Decision Sciences: 0.57× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 1.37× its world share, 10 worksEconomics, Econometr…Psychology: 0.58× its world share, 6 worksPsychologySocial Sciences: 0.05× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.1×. Every wedge is a field page.

All 23 fields, with their numbers
  1. Immunology and Microbiology4.13×14 works
  2. Biochemistry, Genetics and Molecular Biology3.40×62 works
  3. Medicine3.36×220 works
  4. Economics, Econometrics and Finance1.37×10 works
  5. Pharmacology, Toxicology and Pharmaceutics0.69×1 works
  6. Psychology0.58×6 works
  7. Decision Sciences0.57×2 works
  8. Chemical Engineering0.56×1 works
  9. Neuroscience0.53×3 works
  10. Earth and Planetary Sciences0.43×2 works
  11. Mathematics0.43×2 works
  12. Health Professions0.40×4 works
  13. Dentistry0.38×1 works
  14. Nursing0.25×0 works
  15. Chemistry0.21×1 works
  16. Arts and Humanities0.19×2 works
  17. Materials Science0.10×1 works
  18. Agricultural and Biological Sciences0.09×1 works
  19. Computer Science0.09×2 works
  20. Engineering0.06×3 works
  21. Social Sciences0.05×2 works
  22. Physics and Astronomy0.03×0 works
  23. Business, Management and Accounting0.01×0 works

Who are the top researchers at Sarah Cannon?

Ranked on the quality score, Melissa Lynne Johnson, Howard A. Burris and Jeffrey R. Infante lead among researchers whose main affiliation is Sarah Cannon.

  1. 1 Melissa Lynne Johnson United States · #14,373 worldwide 26k citations · 868 works
  2. 2 Howard A. Burris United States · #17,125 worldwide 73k citations · 1,151 works
  3. 3 Jeffrey R. Infante United States · #21,676 worldwide 32k citations · 564 works
  4. 4 David Robert Spigel United States · #23,503 worldwide 80k citations · 903 works
  5. 5 Johanna C. Bendell United States · #26,381 worldwide 31k citations · 929 works
  6. 6 Erika Paige Hamilton United States · #28,812 worldwide 19k citations · 844 works
  7. 7 Denise Aysel Yardley United States · #38,823 worldwide 28k citations · 561 works
  8. 8 Manish R. Patel United States · #68,001 worldwide 17k citations · 815 works
  9. 9 Walter C. Darbonne United States · #87,687 worldwide 8k citations · 109 works
  10. 10 Susanna Varkey Ulahannan United States · #107,755 worldwide 3.6k citations · 265 works
All ranked researchers at Sarah Cannon

What are the most cited papers from Sarah Cannon?

The most cited paper from Sarah Cannon is "Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer" (Suzanne Louise Topalian et al., 2012), with 12,842 citations. Next come "Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer" (11,036) and "Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer" (9,557).

Most cited papers
#PaperReleasedCitations
1 Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer Suzanne Louise Topalian et al. · New England Journal of Medicine Open access 14 Jun 2012 12,842
2 Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer Herbert I. Hurwitz, Louis Fehrenbacher, William F. Novotny et al. · New England Journal of Medicine Open access 2 Jun 2004 11,036
3 Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer H. Borghaei et al. · New England Journal of Medicine Open access 27 Sep 2015 9,557
4 Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer Julie Renee Brahmer et al. · New England Journal of Medicine Open access 31 May 2015 8,632
5 Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine Daniel D. Von Hoff et al. · New England Journal of Medicine Open access 16 Oct 2013 6,826
All 60 most cited papers, with filters and sorting

Which keywords describe research at Sarah Cannon?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Targeted Therapy, Clinical Trials, Breast Cancer, Prognostic Factors, Lymphoma and Cancer Immunotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy40▲ 17×21 topics
  2. Immunotherapy40▲ 16×18 topics
  3. Targeted Therapy34▲ 45×5 topics
  4. Clinical Trials28▲ 12×8 topics
  5. Breast Cancer26▲ 30×10 topics
  6. Prognostic Factors25▲ 17×14 topics
  7. Lymphoma24▲ 44×3 topics
  8. Cancer Immunotherapy24▲ 45×3 topics
  9. Tumor Microenvironment24▲ 15×8 topics
  10. Tumor Regression21▲ 54×2 topics
  11. Cancer20▲ 4.4×40 topics
  12. Cancer Therapy18▲ 9.3×16 topics
  13. CAR T Cells18▲ 72×1 topic
  14. Chimeric Antigen Receptor18▲ 72×1 topic
  15. Leukemia18▲ 63×2 topics
  16. Metastatic Breast Cancer18▲ 88×2 topics
  17. Immune Checkpoint Blockade14▲ 37×1 topic
  18. PD-1 and PD-L114▲ 37×1 topic
  19. PET Imaging14▲ 25×4 topics
  20. Genomic Profiling14▲ 39×2 topics
  21. Metastatic12▲ 56×2 topics
  22. ALK Inhibitors12▲ 58×1 topic
  23. Biomarkers12▲ 5.2×10 topics
  24. EGFR Mutations12▲ 58×1 topic
  25. Treatment Guidelines12▲ 17×2 topics
  26. Cell-Free DNA12▲ 37×2 topics
  27. Genomic Instability12▲ 32×3 topics
  28. Metastasis12▲ 10×12 topics
  29. Cell Cycle Control12▲ 102×2 topics
  30. Rituximab12▲ 24×2 topics
  31. CDK4/6 Inhibitors12▲ 118×1 topic
  32. Palbociclib12▲ 118×1 topic
  33. Cancer Genomics11▲ 46×1 topic
  34. Monoclonal Antibody11▲ 60×2 topics
  35. Mutational Signatures11▲ 46×1 topic
  36. Receptor tyrosine kinases11▲ 82×2 topics
  37. Trastuzumab11▲ 64×2 topics
  38. EGFR11▲ 99×1 topic
  39. HER211▲ 99×1 topic
  40. Monoclonal Antibodies10▲ 32×2 topics

Which research topics does Sarah Cannon publish most on?

By volume in 2022-now: CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Advanced Breast Cancer Therapies.

  1. 1 CAR-T cell therapy research Oncology 18 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 14 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 12 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 12 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 11 works
  6. 6 HER2/EGFR in Cancer Research Oncology 11 works
  7. 7 Lung Cancer Research Studies Oncology 7 works
  8. 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 7 works
  9. 9 Cancer Treatment and Pharmacology Oncology 6 works
  10. 10 Biofield Effects and Biophysics Physiology 6 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.9%not open69.1%

World: 40% of research is openly available.

with international co-authors30.6%domestic only69.4%

World: 18% is written across borders.

How has Sarah Cannon's research output changed?

Output in 2022-2025 was 24% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Sarah Cannon as a percentage of every work published that year, 0.0014% in 2024.

still counting0.0010%0.0020%Sarah Cannon0.0012% in 202519801990200020102020

Fractional works of Sarah Cannon over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%30%Sarah Cannon21.1% in 2025all institutions10.0% in 202520102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 26.4% in 2007.

Other research institutions in Nashville

All research institutions in Nashville

Share Sarah Cannon's ranking

Sarah Cannon on Science Explorer

A card with Sarah Cannon's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Sarah Cannon. Posts are plain text and can be reported.